Identifai Genetics Limited

A$0.41As of Sun 8 Nov 2026, 12:00 UTC
ASX:ID1Healthcare
Country Australia
PE (Fwd) •••
TSR 10Y CAGR —
Div yield —
ROE (433.88%)
Diagnostics & Research
Beta (5Y) —
PE TTM —
TSR TTM —
Mkt cap A$78.71M
ROIC (339.33%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.415
1.27%
(46.18%)
Hold 2|0|11|6|3
4Q25
1Q26
2Q26
3Q26
Earnings per share$
—
—
—
—
8.45%
9.91%
15.86%
15.18%
Revenue$M
4.630
4.715
4.727
4.849
0.64%
5.05%
8.15%
10.17%
Peers (US$54.06M)
Cap (US$)
PE
40.90M
28.11x
54.39M
36.49x
Capital
TTM
5Y
10Y
Leveragex
0.123
(0.109)
(0.082)
EBIT/Intx
1.861
0.538
0.471
Own earn%
149.77
172.06
151.79
Sh yield%
42.14
38.51
39.42
Owners
Insiders/Inst%
9.64
67.48
Short interest%
3.31
SBC / revenue%
4.98
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
5
Op margin range%
12–17
$1 testx
—
Incr. ROIC%
6